143 related articles for article (PubMed ID: 27940059)
1. Use of the levonorgestrel 52-mg intrauterine system in adolescent and young adult solid organ transplant recipients: a case series.
Huguelet PS; Sheehan C; Spitzer RF; Scott S
Contraception; 2017 Apr; 95(4):378-381. PubMed ID: 27940059
[TBL] [Abstract][Full Text] [Related]
2. A case series on the use of levonorgestrel 52 mg intrauterine system after organ transplant.
Juliato CRT; Stahlschmidt P; Fernandes A; Monteiro I; Bahamondes L
Contraception; 2018 Sep; 98(3):252-254. PubMed ID: 29746814
[TBL] [Abstract][Full Text] [Related]
3. Controversies in family planning: intrauterine device placement in solid organ transplant patients.
Gordon C; Harken T
Contraception; 2019 Sep; 100(3):250-252. PubMed ID: 31153820
[TBL] [Abstract][Full Text] [Related]
4. Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system.
Eisenberg DL; Schreiber CA; Turok DK; Teal SB; Westhoff CL; Creinin MD;
Contraception; 2015 Jul; 92(1):10-6. PubMed ID: 25934164
[TBL] [Abstract][Full Text] [Related]
5. Use of the levonorgestrel-releasing intrauterine system in renal transplant recipients: a retrospective case review.
Ramhendar T; Byrne P
Contraception; 2012 Sep; 86(3):288-9. PubMed ID: 22305914
[TBL] [Abstract][Full Text] [Related]
6. Six-year contraceptive efficacy and continued safety of a levonorgestrel 52 mg intrauterine system.
Westhoff CL; Keder LM; Gangestad A; Teal SB; Olariu AI; Creinin MD
Contraception; 2020 Mar; 101(3):159-161. PubMed ID: 31786203
[TBL] [Abstract][Full Text] [Related]
7. A prospective assessment of pelvic infection risk following same-day sexually transmitted infection testing and levonorgestrel intrauterine system placement.
Turok DK; Eisenberg DL; Teal SB; Keder LM; Creinin MD
Am J Obstet Gynecol; 2016 Nov; 215(5):599.e1-599.e6. PubMed ID: 27180886
[TBL] [Abstract][Full Text] [Related]
8. [Application of levonorgestrel-releasing intrauterine system in early pregnancy: a case report].
Gardyszewska A; Czajkowski K
Ginekol Pol; 2012 Dec; 83(12):950-2. PubMed ID: 23488301
[TBL] [Abstract][Full Text] [Related]
9. Acceptability of randomization to levonorgestrel versus copper intrauterine device among women requesting IUD insertion for contraception.
Achilles SL; Chen BA; Lee JK; Gariepy AM; Creinin MD
Contraception; 2015 Dec; 92(6):572-4. PubMed ID: 26297203
[TBL] [Abstract][Full Text] [Related]
10. Immediate postabortion initiation of levonorgestrel implants reduces the incidence of births and abortions at 2 years and beyond.
Rose SB; Garrett SM; Stanley J
Contraception; 2015 Jul; 92(1):17-25. PubMed ID: 25818594
[TBL] [Abstract][Full Text] [Related]
11. Effects of the levonorgestrel-releasing intrauterine system on cervical mucus quality and sperm penetrability.
Lewis RA; Taylor D; Natavio MF; Melamed A; Felix J; Mishell D
Contraception; 2010 Dec; 82(6):491-6. PubMed ID: 21074010
[TBL] [Abstract][Full Text] [Related]
12. Unprotected intercourse in the 2 weeks prior to requesting emergency intrauterine contraception.
Sanders JN; Howell L; Saltzman HM; Schwarz EB; Thompson IS; Turok DK
Am J Obstet Gynecol; 2016 Nov; 215(5):592.e1-592.e5. PubMed ID: 27349294
[TBL] [Abstract][Full Text] [Related]
13. Continuation of a Levonorgestrel Intrauterine Device During Hematopoietic Stem Cell Transplant: A Case Report.
Brady PC; Soiffer RJ; Ginsburg ES
Anticancer Res; 2017 Apr; 37(4):1985-1987. PubMed ID: 28373471
[TBL] [Abstract][Full Text] [Related]
14. Contraceptive use among solid organ transplant patients: a systematic review.
Paulen ME; Folger SG; Curtis KM; Jamieson DJ
Contraception; 2010 Jul; 82(1):102-12. PubMed ID: 20682148
[TBL] [Abstract][Full Text] [Related]
15. A single-arm phase III study exploring the efficacy and safety of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5 mg), in an Asia-Pacific population.
Fan G; Kang S; Ren M; Weisberg E; Lukkari-Lax E; Roth K; Shin S
Contraception; 2017 Apr; 95(4):371-377. PubMed ID: 27913229
[TBL] [Abstract][Full Text] [Related]
16. A 3-year follow-up of women with endometriosis and pelvic pain users of the levonorgestrel-releasing intrauterine system.
Petta CA; Ferriani RA; Abrão MS; Hassan D; Rosa e Silva JC; Podgaec S; Bahamondes L
Eur J Obstet Gynecol Reprod Biol; 2009 Apr; 143(2):128-9. PubMed ID: 19181433
[No Abstract] [Full Text] [Related]
17. Use of the levonorgestrel releasing-intrauterine system in nulliparous women--a non-interventional study in Sweden.
Marions L; Lövkvist L; Taube A; Johansson M; Dalvik H; Øverlie I
Eur J Contracept Reprod Health Care; 2011 Apr; 16(2):126-34. PubMed ID: 21417562
[TBL] [Abstract][Full Text] [Related]
18. The levonorgestrel-releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis.
de Sá Rosa e Silva AC; Rosa e Silva JC; Nogueira AA; Petta CA; Abrão MS; Ferriani RA
Fertil Steril; 2006 Sep; 86(3):742-4. PubMed ID: 16784745
[TBL] [Abstract][Full Text] [Related]
19. Algorithm for nonvisible strings of levonorgestrel intrauterine system.
Vilos GA; Di Cecco R; Marks J
J Minim Invasive Gynecol; 2010; 17(6):805-6. PubMed ID: 20955995
[TBL] [Abstract][Full Text] [Related]
20. Levonorgestrel-releasing intrauterine system for the management of heavy menstrual bleeding in women with inherited bleeding disorders: long-term follow-up.
Chi C; Huq FY; Kadir RA
Contraception; 2011 Mar; 83(3):242-7. PubMed ID: 21310286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
